Learn more

PHARMEXA INC

Overview
  • Total Patents
    34
About

PHARMEXA INC has a total of 34 patent applications. Its first patent ever was published in 1993. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are BN IMMUNOTHERAPEUTICS INC, STABILITECH LTD and MYCOMAGIC BIOTECHNOLOGY CO LTD.

Patent filings per year

Chart showing PHARMEXA INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Sette Alessandro 24
#2 Newman Mark J 15
#3 Chesnut Robert 12
#4 Sidney John 11
#5 Celis Esteban 11
#6 Grey Howard M 11
#7 Southwood Scott 11
#8 Alexander Jeffery L 8
#9 Livingston Brian D 6
#10 Kubo Ralph T 6

Latest patents

Publication Filing date Title
JP2010001303A Hla-binding peptide and use thereof
US2009311283A1 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
CA2658559A1 Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
WO2008054540A2 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
WO2005120563A2 Induction of an immune response against streptococcus pneumoniae polysaccharides
EP1732598A2 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
US2005063983A1 Inducing cellular immune responses to hepatitis B virus using peptide compositions
US7462354B2 Method and system for optimizing minigenes and peptides encoded thereby
EP1842549A2 Optimized minigenes and peptides encoded thereby
EP1230268A2 Heteroclitic analogs of class i epitopes
EP0735893A1 Pan dr-binding peptides for enhancement of the immune response